Overall, these results indicate that in the context of lung adenocarcinoma, colon carcinoma, and melanoma, TH9 cells promote activation of adaptive anti-tumor immune responses through their secretion of IL-9 and IL-21 (Fig. 1). This evidence concerns the gene IL9 and melanoma.